Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients.

Giovanni MarascoElton DajtiFederico RavaioliLuigina Vanessa AlemanniFabiana CapuanoKamela GjiniLuigi ColecchiaGiovanni PuppiniCaterina CusumanoMatteo RenzulliRita GolfieriDavide FestiAntonio Colecchia

Published in: Hepatology international (2020)

SSM could be a reliable non-invasive test for the assessment of hemodynamic response to NSBB therapy as primary prophylaxis for HRV. Similar to HVPG, SSM reduction ≥ 10% is able to assess hemodynamic response.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes